Poolbeg Pharma and CytoReason identify "very exciting influenza targets"

By Proactive Investors / June 29, 2023 / www.youtube.com / Article Link


Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington and CytoReason co-founder and CEO David Harel ...

Recent News

Immediate trigger for crash was new Fed Chairman pick
February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline
February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?
January 26, 2026 / www.canadianminingreport.com

Gold stocks explode up as equity markets languish
January 26, 2026 / www.canadianminingreport.com

Gold stocks outpace flat large caps
January 19, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok